Business
Coronavirus vaccine: Oxford, AstraZeneca resume trial after patient’s serious side-effect – PerthNow
Days after a vaccine trial was suspended following a reported side-effect in a UK patient, Oxford University has announced the study will resume.
Oxford University has announced it is resuming a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca, a move that comes days after the study was suspended following a reported side-effect in a UK patient.
In a statement on Saturday, the university confirmed the restart across all of its UK clinical trial sites after regulators gave the go-ahead following the pause on Sunday.
The independent review process has concluded and following the recommendations of…
-
Business20 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News23 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses
-
Noosa News23 hours agoNick Cave and The Bad Seeds Are Bringing Their ‘Wild God’ Tour to Australia and New Zealand in 2026
-
Business22 hours agoWhat’s Bell Potter’s take on Endeavour Group shares following earnings results?